Leila A. Haidari
Pittsburgh Supercomputing Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Leila A. Haidari.
PLOS ONE | 2013
Leila A. Haidari; Diana L. Connor; Angela R. Wateska; Shawn T. Brown; Leslie E. Mueller; Bryan A. Norman; Michelle M. Schmitz; Proma Paul; Jayant Rajgopal; Joel S. Welling; Jim Leonard; Sheng I. Chen; Bruce Y. Lee
Background When addressing the urgent task of improving vaccine supply chains, especially to accommodate the introduction of new vaccines, there is often a heavy emphasis on stationary storage. Currently, donations to vaccine supply chains occur largely in the form of storage equipment. Methods This study utilized a HERMES-generated detailed, dynamic, discrete event simulation model of the Niger vaccine supply chain to compare the impacts on vaccine availability of adding stationary cold storage versus transport capacity at different levels and to determine whether adding stationary storage capacity alone would be enough to relieve potential bottlenecks when pneumococcal and rotavirus vaccines are introduced by 2015. Results Relieving regional level storage bottlenecks increased vaccine availability (by 4%) more than relieving storage bottlenecks at the district (1% increase), central (no change), and clinic (no change) levels alone. Increasing transport frequency (or capacity) yielded far greater gains (e.g., 15% increase in vaccine availability when doubling transport frequency to the district level and 18% when tripling). In fact, relieving all stationary storage constraints could only increase vaccine availability by 11%, whereas doubling the transport frequency throughout the system led to a 26% increase and tripling the frequency led to a 30% increase. Increasing transport frequency also reduced the amount of stationary storage space needed in the supply chain. The supply chain required an additional 61,269L of storage to relieve constraints with the current transport frequency, 55,255L with transport frequency doubled, and 51,791L with transport frequency tripled. Conclusions When evaluating vaccine supply chains, it is important to understand the interplay between stationary storage and transport. The HERMES-generated dynamic simulation model showed how augmenting transport can result in greater gains than only augmenting stationary storage and can reduce stationary storage needs.
Vaccine | 2016
Leila A. Haidari; Shawn T. Brown; Marie Ferguson; Emily Bancroft; Marie L. Spiker; Allen Wilcox; Ramya Ambikapathi; Vidya Sampath; Diana L. Connor; Bruce Y. Lee
BACKGROUND Immunization programs in low and middle income countries (LMICs) face numerous challenges in getting life-saving vaccines to the people who need them. As unmanned aerial vehicle (UAV) technology has progressed in recent years, potential use cases for UAVs have proliferated due to their ability to traverse difficult terrains, reduce labor, and replace fleets of vehicles that require costly maintenance. METHODS Using a HERMES-generated simulation model, we performed sensitivity analyses to assess the impact of using an unmanned aerial system (UAS) for routine vaccine distribution under a range of circumstances reflecting variations in geography, population, road conditions, and vaccine schedules. We also identified the UAV payload and UAS costs necessary for a UAS to be favorable over a traditional multi-tiered land transport system (TMLTS). RESULTS Implementing the UAS in the baseline scenario improved vaccine availability (96% versus 94%) and produced logistics cost savings of
Vaccine | 2015
Allison Portnoy; Sachiko Ozawa; Simrun Grewal; Bryan A. Norman; Jayant Rajgopal; Katrin M. Gorham; Leila A. Haidari; Shawn T. Brown; Bruce Y. Lee
0.08 per dose administered as compared to the TMLTS. The UAS maintained cost savings in all sensitivity analyses, ranging from
PLOS ONE | 2016
Francesca Pillemer; Rebecca Anhang Price; Suzanne Paone; G. Daniel Martich; Steve Albert; Leila A. Haidari; Glenn Updike; Robert S. Rudin; Darren Liu; Ateev Mehrotra
0.05 to
Vaccine | 2015
Leila A. Haidari; Brian Wahl; Shawn T. Brown; Lois Privor-Dumm; Cecily Wallman-Stokes; Katie Gorham; Diana L. Connor; Angela R. Wateska; Benjamin Schreiber; Hamadou M. Dicko; Mélanie Avella; Bruce Y. Lee
0.21 per dose administered. The minimum UAV payloads necessary to achieve cost savings over the TMLTS, for the various vaccine schedules and UAS costs and lifetimes tested, were substantially smaller (up to 0.40L) than the currently assumed UAV payload of 1.5L. Similarly, the maximum UAS costs that could achieve savings over the TMLTS were greater than the currently assumed costs under realistic flight conditions. CONCLUSION Implementing a UAS could increase vaccine availability and decrease costs in a wide range of settings and circumstances if the drones are used frequently enough to overcome the capital costs of installing and maintaining the system. Our computational model showed that major drivers of costs savings from using UAS are road speed of traditional land vehicles, the number of people needing to be vaccinated, and the distance that needs to be traveled.
Nutrition Reviews | 2017
Bruce Y. Lee; Sarah M. Bartsch; Yeeli Mui; Leila A. Haidari; Marie L. Spiker; Joel Gittelsohn
While new mechanisms such as advance market commitments and co-financing policies of the GAVI Alliance are allowing low- and middle-income countries to gain access to vaccines faster than ever, understanding the full scope of vaccine program costs is essential to ensure adequate resource mobilization. This costing analysis examines the vaccine costs, supply chain costs, and service delivery costs of immunization programs for routine immunization and for supplemental immunization activities (SIAs) for vaccines related to 18 antigens in 94 countries across the decade, 2011-2020. Vaccine costs were calculated using GAVI price forecasts for GAVI-eligible countries, and assumptions from the PAHO Revolving Fund and UNICEF for middle-income countries not supported by the GAVI Alliance. Vaccine introductions and coverage levels were projected primarily based on GAVIs Adjusted Demand Forecast. Supply chain costs including costs of transportation, storage, and labor were estimated by developing a mechanistic model using data generated by the HERMES discrete event simulation models. Service delivery costs were abstracted from comprehensive multi-year plans for the majority of GAVI-eligible countries and regression analysis was conducted to extrapolate costs to additional countries. The analysis shows that the delivery of the full vaccination program across 94 countries would cost a total of
Journal of Public Health Management and Practice | 2013
Leila A. Haidari; Diana L. Connor; Angela R. Wateska; Shawn T. Brown; Leslie E. Mueller; Bryan A. Norman; Michelle M. Schmitz; Proma Paul; Jayant Rajgopal; Joel S. Welling; Jim Leonard; Erin Claypool; Yu Ting Weng; Sheng I. Chen; Bruce Y. Lee
62 billion (95% uncertainty range:
Vaccine | 2017
Bruce Y. Lee; Patrick Wedlock; Leila A. Haidari; Kate Elder; Julien Potet; Rachel Manring; Diana L. Connor; Marie L. Spiker; Kimberly Bonner; Arjun Rangarajan; Delphine Hunyh; Shawn T. Brown
43-
Vaccine | 2016
Leslie E. Mueller; Leila A. Haidari; Angela R. Wateska; Roslyn J. Phillips; Michelle M. Schmitz; Diana L. Connor; Bryan A. Norman; Shawn T. Brown; Joel S. Welling; Bruce Y. Lee
87 billion) over the decade, including
Vaccine | 2017
Bruce Y. Lee; Leila A. Haidari
51 billion (